Lv1
20 积分 2026-04-06 加入
Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial
34分钟前
待确认
Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial
1小时前
已完结
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
4小时前
已完结
皖公网安备34019202002308
